2016-2020 Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

March 2016 | 407 pages | ID: 22B1C224D39EN
Venture Planning Group

Abstracts

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from VPGMarketResearch contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Contents

INTRODUCTION

GLOBAL MARKET TRENDS AND EMERGING TECHNOLOGIES

A. DNA Sequencing
B. DNA and RNA Probe Technology
C. Detection Technologies
D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Cancer Molecular Diagnostics Testing
  1. Overview
  2. Major Cancer Types
  3. Oncogenes
H. Genetic Diseases Molecular Diagnostic Testing
  1. Overview
  2. Nucleic Acid Amplification
  3. Chromosome Imaging
  4. Genomics Technologies
  5. Proteomics Technologies
  6. Current Pharmacogenomic Testing
  7. Major Diseases
I. Forensic Molecular Diagnostics Testing
  1. Overview
  2. Multilocus and Single Locus Probes
  3. The FBI
  4. DNA Profile Data Banks
  5. Judicial Implementation
  6. Major Crime Categories
  7. Factors Contributing to the DNA Probe Major Expansion
J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
K. Other Molecular Diagnostic Testing Applications
L. Competing/Complementing Technologies

GERMANY

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Market Segment
  Sales Forecasts by Market Segment
  Major Supplier Sales and Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

COMPETITIVE PROFILES

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

APPENDIXES

List Of Tables

LIST OF TABLES

Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
Germany, Laboratories Performing DNA Sequencing by Market Segment
Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany, Molecular Diagnostic Test Volume Forecast By Major Application
Germany, Molecular Diagnostic Market Forecast By Major Application
Germany, Molecular Diagnostics Market by Major Supplier